Business1 min read

Dr Lal PathLabs posts higher quarterly profit on strong diagnostic test demand

By · Published by Everything Blog

In short

Dr Lal PathLabs expanded its consolidated net profit to 1.92 billion rupees for the quarter ended September 30, supported by an operational revenue climb of nearly 20% to 8.74 billion rupees. Strong public appetite for diagnostic screenings translated into a 13.6% increase in the total volume of patient samples tested. Group CFO Ved Goel stated that heightened consumer awareness, greater test access, and wider sector consolidation continue to benefit large, quality-accredited providers.

Key points

  • Expanding adoption of preventive check-ups and broader healthcare access are driving sust…: Expanding adoption of preventive check-ups and broader healthcare access are driving sustained top-line growth across the diagnostic sector.
  • Industry consolidation is creating substantial advantages for large, established healthca…: Industry consolidation is creating substantial advantages for large, established healthcare providers with expansive national lab networks.
  • Investor confidence in the laboratory chain strengthened with company shares advancing by…: Investor confidence in the laboratory chain strengthened with company shares advancing by 3.6% after the earnings release.

Sources checked by our analysis pipeline: 1

The Indian lab operator's consolidated net profit for the three months ended September 30 rose to 1.92 billion rupees ($20.27 million), from 1.51 billion rupees a year earlier.

Shares of the company were up 3.6%

Dr Lal reported a near 20% increase in consolidated revenue from operations to 8.74 billion rupees during the quarter

"The diagnostics industry continues to benefit from increasing healthcare awareness, rising adoption of preventive health check-ups, and expanding access to diagnostic services across India," said Group Chief Financial Officer and CEO, international business, Ved Goel

The company, which operated 312 labs as of March 31, tested 13.6% more samples in the second quarter

"The organized diagnostics sector is also witnessing sustained consolidation, creating opportunities for scaled players with strong quality credentials and nationwide reach," Goel said.

(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

Subscribe to ET…

Business